North American Prodromal Synucleinopathy Consortium
Status: Enrolling_by_invitation
Location: See all (10) locations...
Study Type: Observational
SUMMARY
This study will enroll participants with idiopathic rapid eye movement (REM) sleep behavior disorder (RBD), for the purpose of preparing for a clinical trial of neuroprotective treatments against synucleinopathies.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Idiopathic REM sleep behavior disorder
Locations
United States
Arizona
Banner Sun Health Research Institute
Sun City
California
University of California Los Angeles
Los Angeles
Stanford University
Redwood City
Georgia
Emory University
Atlanta
Massachusetts
Massachusetts General Hospital
Boston
Minnesota
University of Minnesota
Minneapolis
Mayo Clinic
Rochester
Missouri
Washington University
Saint Louis
Oregon
Portland VA Medical Center
Portland
Other Locations
Canada
McGill University
Montréal
Time Frame
Start Date: 2018-08-29
Completion Date: 2026-07-31
Participants
Target number of participants: 500
Authors
Related Therapeutic Areas
Sponsors
Collaborators: Mayo Clinic, Emory University, Stanford University, McGill University, Massachusetts General Hospital, National Institute on Aging (NIA), University of Minnesota, University of California, Los Angeles, Banner Health, Portland VA Medical Center
Leads: Washington University School of Medicine